ADENOSCAN Drug Patent Profile
✉ Email this page to a colleague
When do Adenoscan patents expire, and when can generic versions of Adenoscan launch?
Adenoscan is a drug marketed by Astellas and is included in one NDA.
The generic ingredient in ADENOSCAN is adenosine. There are twenty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the adenosine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adenoscan
A generic version of ADENOSCAN was approved as adenosine by HIKMA on June 16th, 2004.
Summary for ADENOSCAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 161 |
Clinical Trials: | 10 |
Patent Applications: | 2,138 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ADENOSCAN at DailyMed |
Recent Clinical Trials for ADENOSCAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
NYU Langone Health | N/A |
University of Utah | Early Phase 1 |
National Heart, Lung, and Blood Institute (NHLBI) | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for ADENOSCAN
US Patents and Regulatory Information for ADENOSCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-001 | May 18, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-002 | May 18, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ADENOSCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-002 | May 18, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-001 | May 18, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Astellas | ADENOSCAN | adenosine | SOLUTION;INTRAVENOUS | 020059-001 | May 18, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ADENOSCAN
See the table below for patents covering ADENOSCAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1301652 | ADMINISTRATION INTRAVEINEUSE PROGRESSIVE DE L'ADENOSINE A DES SUJETS HUMAINS (CONTINUOUS INTRAVENOUS INFUSION OF ADENOSINE TO HUMAN PATIENTS) | ⤷ Try a Trial |
Denmark | 253187 | ⤷ Try a Trial | |
Germany | 19975044 | ⤷ Try a Trial | |
European Patent Office | 0354638 | ⤷ Try a Trial | |
Japan | 2914454 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |